0000000000523014

AUTHOR

K. Johansson

showing 1 related works from this author

A randomized, multicenter, open-label controlled phase 2 trial of Foxy-5 as neoadjuvant therapy in patients with WNT5A negative colon cancer

2019

Oncologymedicine.medical_specialtybusiness.industryColorectal cancermedicine.medical_treatmentHematologymedicine.diseaseWNT5AOncologyInternal medicineMedicineIn patientOpen labelbusinessNeoadjuvant therapyWnt 5a proteinAnnals of Oncology
researchProduct